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INTRODUCTION
Neonatal necrotising enterocolitis (NEC) is a disease that
affects the gastrointestinal tract of neonates and is charac-
terised by focal or diffuse intestinal necrosis. In 90% of
cases NEC affects preterm infants, particularly those with
extremely low birth weight (ELBW), i.e. weight under 1000
grams, and very low birth weight (VLBW), i.e., 1000–1500
grams (Hall et al., 2013). The incidence of NEC varies from
1 to 3 in 1000 live births and NEC affects 1 to 5% of infants
in neonatal intensive care units (NICU) (Maheshwari et al.,
2011). The incidence of NEC continues to increase due to
more ELBW and VLBW infants being born, as more pre-
term infants are treated in the NICU and new technologies
are being introduced. Risk factors such as immaturity of in-
testines due to prematurity, initiation of enteral feedings and
bacterial infection play a significant role in the pathogenesis
of NEC.
The diagnostics of NEC is based on clinical examination,
and radiological and laboratory findings. In 1978, Dr. Mar-
tin Bell described three clinical stages of NEC, and the
Bell’s staging criteria have been modified various times.
The criteria distinguish initial, proven, and surgical NEC.
The stage of NEC depends on various clinical signs. The
typical local signs of NEC are abdominal distention, ab-
dominal wall oedema and erythema, ascites, and increased
gastric residuals with or without bile, emesis, occult or
grossly bloody stools. Systemic signs include lethargy, ap-
nea, signs of septic shock, but laboratory findings show
thrombocytopenia, elevated inflammatory markers (i.e. leu-
kocytosis or leukopenia, elevated C reactive protein level,
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Necrotising enterocolitis (NEC) is one of the leading causes of neonatal morbidity, mortality and
surgical emergencies. As the survival rate of extremely low birth weight (ELBW) infants is rising,
so is the risk of NEC. The aim of this study was to compare diagnostics parameters like clinical
and radiological findings and laboratory indicators and the treatment and outcome of NEC pa-
tients from 2000 till 2007 (Group 1) and from 2008 till 2016 (Group 2) treated in Neonatology
Clinic (NC) of Children’s Clinical University Hospital (CCUH). In the rectrospective study, 277
newborns were divided among Group I and Group II – 105 and 172 patients, respectively. There
were no statistically significant differences between both study groups in mean gestational age
and birth weight. In both groups the first signs of NEC appeared on average eight days after birth.
Differences in the diagnostic method used in both groups were not statistically significant; specific
radiological findings were seen in approximately 1/3 of the cases. There were statistically signifi-
cant differences in the management of NEC and patient mortality. Conservative therapy was ap-
plied in 70.0% of patients in both study groups. Over time, peritoneal drainage (PPD) as the sole
surgical treatment decreased by 6.4%, but PPD with following enterostomy decreased by 8.9%.
In Group 2 mortality of NEC patients decreased by 17.4%. Mortality among surgically treated
NEC patients decreased as well, by 9.0%.
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interleukin 6), metabolic acidosis and electrolyte imbalance.
Radiography (i.e. abdominal ultrasound and abdominal X-
ray) plays a significant role in the diagnostics of NEC. Pa-
thognomonic radiological findings of NEC are intestinal
pneumatosis (intramural gas due to the production of gas
from bacterial fermentation in the intestinal wall), fixed
bowel loops, signs of ileus and pneumoperitoneum. Free
fluid in the abdominal and pleural cavity, pneumoperito-
neum and mass lesions can be visualised by ultrasonogra-
phy.
There are two treatment options: medical or nonsurgical
treatment and surgical treatment performed with additional
medical treatment. Medical management includes nil per os,
complete bowel rest and gastric decompression, broad-
spectrum antibiotics, correction of hypovolemia and acid-
base imbalance, blood transfusions in case of thrombocy-
topenia and/or anaemia and total parenteral feeding. Abso-
lute indications for surgical management are pneumoperito-
neum and peritonitis. The surgical approach depends on the
infant’s health condition, the staging of NEC and intraop-
erative findings. Laparotomy with resection of necrotic
bowel with anastomosis or creation of enterostomy are
known as the traditional surgical approaches. Primary peri-
toneal drainage (PPD), which can be followed or not by en-
terostomy in ELBW infants, can be used as an alternative
approach (Downard et al., 2012).
NEC is a devastating disease in the neonatal period due to
its various clinical findings, aggressive and possibly fulmi-
nant course. It is one of the most common causes of neona-
tal morbidity, mortality and surgical emergencies (Gephard
et al., 2013).
The aim of this study was to compare diagnostics parame-
ters like clinical and radiological findings and laboratory in-
dicators and the treatment and outcome of NEC patients
from 2000 till 2007 and from 2008 till 2016.
MATERIALS AND METHODS
The Ethical Committee of Children’ Clinical University
Hospital approved the study protocol, which was created in
accordance with the Patient Data Protection Regulation.
A retrospective study was performed from January 2000 to
December 2016, which included 277 patients from the Neo-
natology Clinic (NC) of the Children’s Clinical University
Hospitals’ (CCUH) diagnosed with NEC according to Inter-
national Classification of Diseases 10th revision (ICD-10).
All the medical records with code P77 (Necrotising entero-
colitis of newborn) were analysed (ICD-10, 2016). Patients
were divided into two groups: Group 1 – patients hospital-
ised in CCUH NC from January 2000 to December 2007 (n
= 105), and Group 2 – patients hospitalised from January
2008 to December 2016 (n = 172). Assessed parameters
were compared between the two groups including sex, birth
weight, weeks of gestation. The clinical stages of NEC of
both groups were compared according to Bell’s Staging Cri-
teria taking into account the diagnostic parameters. The fol-
lowing diagnostic clinical findings were assessed; general
and local abdominal symptoms, radiological ultrasound and
X-ray findings and laboratory labels (number of leukocytes
and trombocytes, C reactive protein and interleukin 6 levels,
pH and baseline excess (BE) levels of blood gases. The ap-
plied therapies (medical or surgical) were compared for
both groups. Four surgical methods used in both groups
were evaluated and compared: PPD, PPD and following en-
terostomy, bowel resection with the enterostomy and bowel
resection with creation of primary anastomoses. In both
study groups mortality was assessed and compared by birth
weight and treatment management. Data were collected us-
ing Microsoft Excel 2013 and analysed with STATA/IC
v.12.5. The Kruskal-Wallis H and Student T test was ap-
plied.
RESULTS
The sex distribution was similar — 137 (49.5%) male and
140 (50.5%) female newborns. NEC was more common in
ELBW and very low birth weight (VLBW) infants in both
groups — 33 (32.4%) ELBW infants in Group 1 and 71
(41.3%) in Group 2, and 34 (32.4%) VLBW infants in
Group 1 and 50 (29.1 %) — in Group 2. No statistically sig-
nificant difference in mean weeks of gestation was found
between Group 1 and Group 2, i.e. 29.7 (SD = 4.4) and 32.7
(SD = 4.4) weeks of gestation. The first typical signs of
NEC (feeding intolerance, gastric retention, abdominal en-
largement, bloody stools and general signs of sepsis) were
observed in the second week of life and the mean age at the
time of diagnostic was 8.7 (SD = 8.07) and 7.8 (SD = 9.01)
days in Group 1 and Group 2, respectively. The distribution
of three stages according to Bell’s Staging Criteria did not
differ between the two groups: in Group 1 — 51.4%, 23.8%
and 24.8%, in Group 2 — 48.3 %, 27.8% and 23.9% (Table
1). Specific radiological findings suggesting NEC were seen
in 34.3% of cases in Group 1 and 34.5% — in Group 2. As
expected, 68.6% patients in Group 1 and 72.7% in Group 2
received medical management. Surgical management of
NEC differed significantly in both groups. Primary perito-
neal drainage (PPD) as the sole surgery was used relatively
less in Group II: PPD as the sole surgical manipulation in
NEC decreased by 6.4%, and the use of a multi-staged op-
eration with PPD and a following enterostomy decreased by
8.9% between the two time periods. Almost equal percent-
age of patients underwent intestinal resection and enteros-
tomy formation in Group 1 and Group 2, i.e. 13.3% and
13.4%, but intestinal resection and creation of primary anas-
tomosis was chosen only in Group 2 in 2.3% of cases (Fig.
1). A statistically significant difference was found in mor-
tality between the two groups. The overall mortality was
44.8% in Group 1 and 27.3% in Group 2. The distribution
of dead newborns by birth weight between groups did not
differ significantly. In both study groups the highest mor-
tality was in ELBW neonates, i.e., 53.2% and 57.5% in the
two groups, respectively Fig. 2 and Fig. 3). There was a
9.0% decrease of mortality between the two time periods in
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the group of patients treated surgically — the rate of mortal-
ity in Group 1 was 20%, but in Group 2 — 11%. There is a
very variable patient mortality over the years (Fig. 4).
DISCUSSION
There are approximately 20 000 live births each year in Lat-
via, the number of births in the last 17 years has not
changed significantly. In this time period there were 361
798 live births in Latvia and about 6% of them were prema-
ture births. The incidence of NEC in Latvia has been vari-
able, i.e. from 0.2 to 1.6 per 1000 live births (Fig. 5), which
is equivalent to data from other countries — 0.76 to 0.98
per 1000 live births in North America, 0.5 to 5 per 1000 live
births in United Kingdom, and 1.8 per 1000 live births in
Canada (Shnabl 2008; Hall, 2013; Gillfilan 2017). Each
T a b l e 1






Male 50 (47.5%) 87 (52.4%) NS
Female 55 (50.6%) 85 (49.4%) NS
Weeks of gestation (SD) 29.7 (+/- 4.4) 32,7 (+/- 4.4) NS
Birth weight, grams (SD) 2,1 (+/- 1.0) 1.9 (+/- 1.0) NS
First clinical signs of NEC, days of life (SD) 8.7 (+/- 8.1) 7.8 (+/- 9.0) NS
X-ray and US abdominal findings No imaging done, % 37.1 32.8 NS
Nonspecific, % 28.6 31.7
Intestinal pneumatosis, % 16.2 19.3
Pneumoperitoneum, % 18.1 15.2
Bell’s staging I, % 51.4 48.3 NS
II, % 23.8 27.3
III, % 24.8 23.8
Mortality 47 (44.8%) 47 (27.3%) 0.003
SD, standard deviation; NEC, necrotising enterocolitis; NS, not significant
Fig. 1. Treatment used in cases of necrotising enterocolitis
in both study groups (p = 0.005).
Fig. 2. Mortality and survival of patients with necrotising
enterocolitis in Group 1 depending on their birth weight (p <
0.001).
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year there are 5 to 39 new cases of NEC in CCUH NC. In
Latvia all NEC patients from regional perinatal centres are
transported to CCUH according to guidelines for the treat-
ment and care of newborn with NEC. During the time peri-
od from January 2000 to December 2016, there were 19 240
patients in CCUH NC and 1.4% of these patients were diag-
nosed with NEC, which is similar as in NICUs in other
countries, i.e. 2 to 5% (Gupta and Paria, 2016). The variable
incidence of NEC during these years suggests that there
might be diagnostic problems or the diagnosis of NEC
might have different interpretations due to lack of specific
markers of NEC.
In the past few years, there have been a lot of discussions
regarding the definition of NEC. It has been noted that the
lack of specific criteria results in misleading statistics of
NEC in different NICUs, and therefore when using the
Bell’s Staging Criteria, all the risk factors should be take in
consideration (Gupta and Paria 2016; Gephard et al., 2017;
Neu et Pammi, 2017). In most of the cases in premature in-
Fig. 3. Mortality and survival of patients with
necrotisiting enterocolitis in Group 2 depending on
their birth weight (p = 0.058).
Fig. 4 . The mortality (%) of newborns with
necrotisiting enterocolitis.
Fig. 5 . The overall incidence of necrotising
enterocolitis in Latvia.
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fants the onset of NEC is in the second or third week of life
(Maheshwari et al., 2011), although in 25% of cases the on-
set can be even after the age of one month (Clark and
Munchi, 2014). In this study most of the patients developed
first clinical signs of NEC after the first week of life, when
the risk factors associated with pathogenesis of NEC, i.e.
immaturity of intestines due to prematurity, initiation of en-
teral feedings, the type of enteral feedings, bacterial coloni-
sation of the gastrointestinal tract and possible bacterial in-
fection are manifested (Guner et al., 2008). The interaction
of risk factors leads to increased intestinal wall permeabil-
ity, increased epithelial cell apoptosis of intestinal mucosa
and activation of inflammatory marker cascade.
Although NEC usually affects premature infants, it can also
affect infants born in term. Approximately 11% of all the
NEC patients in CCUH NC were term infants with a birth
weight of more than 2500 grams, which was similar to data
in the literature. There are several risk factors of NEC for
term infants, such as asphyxia during labour, respiratory
distress, anaesthesia used during caesarean section, various
prenatal factors and other underlying conditions, e.g. con-
genital heart disease, which causes hypoperfusion and hy-
poxia in gastrointestinal tract (Gephard et al., 2013; Gordon
et al., 2017; Maheshwari et al., 2017).
As our rectospective study showed, in most cases (65.0%)
NEC was diagnosed based on clinical findings. This may
lead to misinterpretation, especially in the first stage of
NEC, when some of the clinical symptoms may be consid-
ered as normal signs of the development of a premature in-
fant, e.g., increased gastric residuals due to decreased motil-
ity of intestines, abdominal distention and meteorism due to
feeding intolerance or the use of continuous positive airway
pressure or bloody stools due to viral infection. This might
be the reason for NEC hyperdiagnosis suggested by chang-
ing statistics — increasing NEC incidence, increasing the
percentage medically treated NEC, reducing the percentage
of surgically treated NEC, as well as reducing mortality.
This means that in the clinical practice, more accurate and
specific NEC criteria are required. Specific radiological
findings of NEC in both of our study groups were found in
35.0% of cases, which is less common that described in
other studies — where in 60.5% of cases not only pneumo-
peritoneum but also various other specific signs of NEC
have been found (Coursey et al., 2009), making the diagno-
sis of NEC still based on clinical findings. Literature data
shows that intestinal pneumatosis can be assessed by ultra-
sound earlier than by X-ray imaging and that the sensitivity
of ultrasound is higher by 6.25% (Shebria et al., 2012; Ea-
ton, 2017). There were no statistically significant difference
between X-ray and ultrasound diagnostic methods between
the two study groups. Our study showed that radiologically
diagnosed pneumoperitoneum was reduced by 3.0% in
Group 2, which confirms the decline in the perforative NEC
forms.
The study showed that approximately 60% of the patients
with NEC in Latvia received solely medical management.
The only absolute indication of surgical treatment in case of
NEC is intestinal perforation. In both groups in CCUH NC
surgical management was received by 26 to 29% of pa-
tients, similar as in clinics in United States of America,
United Kingdom, Taiwan, where surgical management was
done in 20 to 40 to 60% of cases (Shnabl et al., 2008;
Young et al., 2009; Wu et al., 2011; Clark et Munshi,
2014). The surgical approach includes PPD, multiple stage
surgeries with PPD and a following enterostomy, lapa-
rotomy with resection of ischemic bowel and creation of
primary enterostomy and resection of ischemic bowel with
primary anastomosis creation. The resection of ischemic
bowel with primary anastomosis was first mentioned in
1979 by Kiesewetter et al. (1979) and lately this approach
has been used more often due to the possibility of avoiding
complications of enterostomy (e.g. prolapse, necrosis, stric-
tures), feeding difficulties and metabolic disturbances (Hall
et al., 2009). The surgical method depends on intraoperative
findings — whether the necrosis of intestines is focal, mul-
tifocal or panintestinal (Hall et al., 2013). The statistically
significant difference between the two groups can be ex-
plained by the decreased usage of PPD in all birth weight
groups and the usage of primary anastomosis in surgical
management since 2008.
Various studies show no significant difference in mortality,
days spent in hospital or late outcome in critically ill ELBW
infants based on surgical approach (Raval and Moss, 2014).
The mortality rate in CCUH due to NEC has decreased by
17.4%, although the overall mortality still is high (27.3%),
as in USA and UK where the mortality rate differs in vari-
ous NICUs and makes up 20 to 50% of cases (Maheshwari
et al., 2011; Gephard et al., 2012). The decrease in mortal-
ity could be attributed to the reduction of perforated form in
the second group. It is known that in cases of NEC the mor-
tality is inversely proportional to the birth weight — mortal-
ity increases if the birth weight is below 1000 grams (Hull
et al., 2014). Up to 42% of patients with NEC in CCUH
were ELBW infants, and therefore the high mortality in this
group of patients was associated with life-threatening un-
derlying conditions of extremely premature infants, e.g.
stage III and IV intraventricular haemorrhages, respiratory
distress syndrome, hypoxic multiorgan failure, acute renal
failure, disseminated intravascular coagulopathy, sepsis etc.
The mortality of surgically treated NEC patients in the time
period has decreased from 20% to 11% and it is lower than
in the United States of America and the United Kingdom,
where the mortality is 30% and 20%, respectively (Hull et
al., 2014; Eaton, 2017), which is associated with the critical
condition of ELBW and VLBW infants in case of intestinal
perforation.
CONCLUSIONS
1. The incidence of NEC in Latvia is similar to the inci-
dence of NEC in other countries.
2. The distribution of three stages according to Bell’s Stag-
ing Criteria did not differ between the study groups (p =
0.64).
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3. Intestinal perforations decreased by 3.0% comparatively
in the NEC patients second group, although there are no sta-
tistically significant differences between radiological NEC
findings between the study groups (p = 0.703).
4. The use of PPD, both as the sole surgical manipulation
and as a multi-stage operation, was reduced in the second
study group (p = 0.005).
5. In the second group the mortality due to NEC decreased
for both medical and surgically treated infants (p = 0.003).
6. In both study groups the highest mortality rate was
among ELBW newborns, but there was no statistically sig-
nificant difference in the mortality of patients with NEC in
the different weight groups between the two patient groups
(p = 0.97).
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NEKROTISKÂ ENTEROKOLÎTA DIAGNOSTIKA UN ÂRSTÇÐANA JAUNDZIMUÐAJIEM LATVIJÂ
Nekrotiskais enterokolîts (NEK) ir viens no bieþâkajiem saslimstîbas, mirstîbas un neatliekamâs íirurìiskâs palîdzîbas sniegðanas
iemesliem neonatâlajâ periodâ. Palielinoties ïoti zema svara priekðlaikus dzimuðo bçrnu izdzîvoðanai, NEK risks turpina pieaugt. Darba
mçríis bija salîdzinât NEK pacientu klîniskâs un radioloìiskâs pazîmes, ârstçðanas taktiku un rezultâtus divos laika periodos —
2000.–2007. g. (I grupa) un 2008.–2016. g. (II grupa), kuri ârstçjuðies Bçrnu klîniskâs universitâtes slimnîcas Neonatoloìijas klînikâ.
Retrospektîvajâ pçtîjumâ tika iekïauti 277 jaundzimuðie ar diagnozi NEK, 105 — I grupâ un 172 — II grupâ. Abâs pçtîjuma grupâs nebija
statistiski ticamu atðíirîbu NEK pacientu vidçjam gestâcijas vecumam un sadalîjumam pçc dzimðanas svara. NEK pirmâs pazîmes abâs
pçtîjuma grupâs parâdîjâs vidçji astoòas dienas pçc dzimðanas. Pielietotajâm diagnostikas metodçm statistiski nozîmîgu atðíirîbu abâs
grupâs nebija — aptuveni 1/3 gadîjumu tika konstatçta NEK specifiska radioloìiska atradne. Statistiski ticama atðíirîba starp abâm
pçtîjuma grupâm tika novçrota pielietotajâ terapijâ un mirstîbâ. Konservatîva terapija abâs pçtîjuma grupâs tika pielietota 70% gadîjumu.
Laika gaitâ samazinâjâs primâras peritoneâlas drenâþas (PPD) veikðana: par 6,4% — kâ vienîgâ íirurìiskâ manipulâcija un par 8,9% —
PPD pielietoðana ar sekojoðu enterostomas izveidoðanu vairâketapu operâcijas ietvaros. II pçtîjuma grupâ mirstîba no NEK bija
samazinâjusies par 17,43%. Íirurìiski ârstçto miruðo pacientu skaits II grupâ samazinâjâs par 9%.
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